Most cited papers from Instituut Verbeeten

Instituut Verbeeten

What are the most cited papers from Instituut Verbeeten?

The most cited paper from Instituut Verbeeten is "Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" (Stefan Paul Aebi, T. Davidson, Günther Gruber et al., 2010), with 2,861 citations. Next come "Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial" (2,615) and "Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial" (1,786).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 151 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Stefan Paul Aebi, T. Davidson, Günther Gruber et al. · Annals of Oncology Open access	May 2010	2,861
2	Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Joël Shapiro et al. · The Lancet Oncology	6 Aug 2015	2,615
3	Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial Carien L. Creutzberg, Wim LJ van Putten, Peter C.M. Koper et al. · The Lancet	Apr 2000	1,786
4	Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer Caro Schaake-Koning, Walter Van den Bogaert, Otilia Dalesio et al. · New England Journal of Medicine	20 Feb 1992	1,289
5	Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer Philip M. Poortmans et al. · New England Journal of Medicine Open access	22 Jul 2015	1,033
6	Duration of Androgen Suppression in the Treatment of Prostate Cancer M. Bolla, Theodorus M. de Reijke, Geertjan van Tienhoven et al. · New England Journal of Medicine Open access	10 Jun 2009	977
7	Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation Harry G M M Bartelink, Jean-Claude Horiot, Philip M. Poortmans et al. · New England Journal of Medicine	8 Nov 2001	954
8	Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial Ben M. Eyck et al. · Journal of Clinical Oncology Open access	23 Apr 2021	818
9	ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer Birgitte Vrou Offersen, Liesbeth Jorinne Boersma, Carine Kirkove et al. · Radiotherapy and Oncology Open access	2015	740
10	Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial Harry G M M Bartelink et al. · The Lancet Oncology Open access	8 Dec 2014	696
11	Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma Michael Schaapveld et al. · New England Journal of Medicine Open access	23 Dec 2015	637
12	Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Elżbieta Senkus, Stella Kyriakides, Frederique Madeleine Penault-Llorca et al. · Annals of Oncology Open access	22 Aug 2013	480
13	Survival after relapse in patients with endometrial cancer: results from a randomized trial☆ Carien L. Creutzberg, Wim L.J. van Putten, Peter C.M. Koper et al. · Gynecologic Oncology	25 Apr 2003	376
14	Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines T. Girinsky, Richard van der Maazen, Lena Specht et al. · Radiotherapy and Oncology	Jun 2006	375
15	The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial Conny Vrieling, Laurence Collette, Alain Fourquet et al. · Radiotherapy and Oncology	Jun 2000	321
16	Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study) Maarten C.C.M. Hulshof, Elisabeth D. Geijsen, Tom Rozema et al. · Journal of Clinical Oncology Open access	8 Jun 2021	316
17	Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM Christian Kirisits, Mark J. Rivard, Dimos Baltas et al. · Radiotherapy and Oncology Open access	30 Nov 2013	315
18	Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group Philip M. Poortmans, Alberto Bossi, Katia Vandeputte et al. · Radiotherapy and Oncology	Aug 2007	314
19	Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis Roel J.H.M. Steenbakkers, Joop C. Duppen, Isabelle Fitton et al. · International Journal of Radiation OncologyBiologyPhysics	29 Sep 2005	309
20	Textbook outcome as a composite measure in oesophagogastric cancer surgery Linde A. D. Busweiler et al. · British journal of surgery Open access	27 Feb 2017	304
21	Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial Philip M. Poortmans et al. · The Lancet Oncology Open access	2 Nov 2020	302
22	Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial Edward Chow, Yvette M. van der Linden, Daniel E. Roos et al. · The Lancet Oncology Open access	22 Dec 2013	299
23	Tolerances for the accuracy of photon beam dose calculations of treatment planning systems Jack L. M. Venselaar, Hans Welleweerd, Ben J. Mijnheer · Radiotherapy and Oncology	Aug 2001	287
24	Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients Mahmut Özsahin, Richard W. C. Tsang, Philip M. Poortmans et al. · International Journal of Radiation OncologyBiologyPhysics	18 Oct 2005	281
25	PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer Anne Sophie V M van den Heerik et al. · International Journal of Gynecological Cancer Open access	12 Oct 2020	251
26	Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) S. Gourgou-Bourgade et al. · Annals of Oncology Open access	28 Feb 2015	250
27	A dosimetric uncertainty analysis for photon‐emitting brachytherapy sources: Report of AAPM Task Group No. 138 and GEC‐ESTRO Larry A. DeWerd, Geoffrey S. Ibbott, Ali Soleimani Meigooni et al. · Medical Physics Open access	14 Jan 2011	248
28	ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1 Birgitte Vrou Offersen, Liesbeth Jorinne Boersma, Carine Kirkove et al. · Radiotherapy and Oncology	2016	247
29	Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review Astrid N. Scholten, Wim L.J. van Putten, Henk Beerman et al. · International Journal of Radiation OncologyBiologyPhysics	Jun 2005	247
30	Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial Paul E. Van Schil, P. Baas, Rabab Mohamed Gaafar et al. · European Respiratory Journal Open access	4 Jun 2010	243
31	Atypical and Malignant Meningioma: Outcome and Prognostic Factors in 119 Irradiated Patients. A Multicenter, Retrospective Study of the Rare Cancer Network David Pasquier, Stefan Bijmolt, Theo Veninga et al. · International Journal of Radiation OncologyBiologyPhysics	6 Mar 2008	234
32	Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’ Sandra Collette, Laurence Collette, Tom Budiharto et al. · European Journal of Cancer	30 Aug 2008	225
33	High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging Arjan Bel, Pieter H. Vos, Patrick T.R. Rodrigus et al. · International Journal of Radiation OncologyBiologyPhysics Open access	May 1996	211
34	Final Results of a Prospective Study Comparing the Local Control of Short-Course and Long-Course Radiotherapy for Metastatic Spinal Cord Compression Dirk Rades, Marisa Lange, Theo Veninga et al. · International Journal of Radiation OncologyBiologyPhysics	7 May 2010	211
35	Quality indicators in breast cancer care Marco Rosselli Del Turco et al. · European Journal of Cancer	3 Aug 2010	207
36	Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study David Knobel, Abderrahim Zouhair, Richard W. C. Tsang et al. · BMC Cancer Open access	5 May 2006	202
37	The evolution of brachytherapy treatment planning Mark J. Rivard, Jack L. M. Venselaar, Luc Beaulieu · Medical Physics Open access	8 May 2009	195
38	The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial Carien L. Creutzberg, Wim L.J. van Putten, Peter C.M. Koper et al. · International Journal of Radiation OncologyBiologyPhysics	Dec 2001	194
39	Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) José S.A. Belderbos, Lon J. Uitterhoeve, Nico van Zandwijk et al. · European Journal of Cancer	4 Nov 2006	190
40	Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882 Ninja F. Antonini, Heather Jones, Jean Claude Horiot et al. · Radiotherapy and Oncology	29 Nov 2006	186
41	Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: Results on survival in the Dutch Bone Metastasis Study Yvette M. van der Linden, Elsbeth Steenland, Hans C. van Houwelingen et al. · Radiotherapy and Oncology	Mar 2006	184
42	Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042) Damien Charles Weber, Carmen Ares, S. Villà et al. · Radiotherapy and Oncology Open access	28 Jun 2018	182
43	The requirements of a specialist Breast Centre A.R.M. Wilson, Lorenza Marotti, Simonetta Bianchi et al. · European Journal of Cancer Open access	19 Aug 2013	180
44	Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Conny Vrieling, Laurence Collette, Alain Fourquet et al. · European Journal of Cancer	23 Apr 2003	177
45	The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma Joke G.J. Letschert, Joos V. Lebesque, Berthe M.P. Aleman et al. · Radiotherapy and Oncology	Aug 1994	177
46	Management of radiation oncology patients with a pacemaker or ICD: A new comprehensive practical guideline in The Netherlands Coen Hurkmans, J. Knegjens, Bing S. Oei et al. · Radiation Oncology Open access	24 Nov 2012	176
47	Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial Bastiaan G. Wortman, Tjalling Bosse, Remi A. Nout et al. · Gynecologic Oncology Open access	3 Aug 2018	172
48	Molecular and biological rationale of hyperthermia as radio- and chemosensitizer Arlene L. Oei, Henny Petra Kok, S.B. Oei et al. · Advanced Drug Delivery Reviews Review	2020	164
49	Observer variation in target volume delineation of lung cancer related to radiation oncologist–computer interaction: A ‘Big Brother’ evaluation Roel J.H.M. Steenbakkers, Joop C. Duppen, Isabelle Fitton et al. · Radiotherapy and Oncology	27 Oct 2005	163
50	Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study Wendy Jeanneret‐Sozzi, Alphonse G. Taghian, Ron Epelbaum et al. · BMC Cancer Open access	Apr 2008	163

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.